Private Capital Management (Florida)’s Quest Diagnostics DGX Stock Holding History

Private Capital Management (Florida)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.71M	Hold	8,700	–	–	0.17%	78
2025 Q4	$1.51M	Hold	8,700	–	–	0.14%	78
2025 Q3	$1.66M	Buy	8,700 +300	+4%	+$53.2K	0.15%	72
2025 Q2	$1.51M	Sell	8,400 -2,000	-19%	-$347K	0.15%	75
2025 Q1	$1.76M	Hold	10,400	–	–	0.19%	55
2024 Q4	$1.57M	Buy	10,400 +1,700	+20%	+$264K	0.16%	53
2024 Q3	$1.35M	Buy	8,700 +500	+6%	+$74.7K	0.14%	57
2024 Q2	$1.12M	Hold	8,200	–	–	0.13%	58
2024 Q1	$1.09M	Buy	8,200 +2,000	+32%	+$259K	0.12%	58
2023 Q4	$855K	Buy	6,200 +1,000	+19%	+$131K	0.1%	76
2023 Q3	$634K	Buy	5,200 +2,700	+108%	+$360K	0.07%	80
2023 Q2	$351K	Sell	2,500 -1,000	-29%	-$138K	0.04%	115
2023 Q1	$495K	Buy	3,500 +1,100	+46%	+$157K	0.06%	86
2022 Q4	$375K	Hold	2,400	–	–	0.05%	80
2022 Q3	$294K	Buy	+2,400	New	+$316K	0.04%	110

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Private Capital Management (Florida)'s DGX Position: Q1 2026 in Review

Private Capital Management (Florida) held its Quest Diagnostics (DGX) position steady in Q1 2026 at 8,700 shares worth $1.71M. The position accounts for 0.17% of the portfolio, ranked #78.

Private Capital Management (Florida) first reported a position in DGX in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.76M in Q1 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Private Capital Management (Florida) held 8,700 shares of Quest Diagnostics worth $1.71M as of Q1 2026.
Private Capital Management (Florida) left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.17% of Private Capital Management (Florida)'s portfolio in Q1 2026, its #78 holding.
Private Capital Management (Florida) first reported a position in Quest Diagnostics in Q3 2022 and has held it in 15 quarters since.
Private Capital Management (Florida)'s Quest Diagnostics position peaked at $1.76M in Q1 2025.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q1 2026, filed 15 May 2026.